Header Logo

Connection

CHRIS AMOS to Incidence

Back to Details
This is a "connection" page, showing publications CHRIS AMOS has written about Incidence.
CHRIS AMOS
Connection Strength
0.504
Incidence
  1. COVID-19 Community Incidence and Associated Neighborhood-Level Characteristics in Houston, Texas, USA. Int J Environ Res Public Health. 2021 02 04; 18(4).
    View in: PubMed
    Score: 0.099
  2. Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations. PLoS One. 2010 May 26; 5(5):e10813.
    View in: PubMed
    Score: 0.047
  3. Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions. Prog Cardiovasc Dis. 2024 Sep-Oct; 86:79-85.
    View in: PubMed
    Score: 0.032
  4. Asbestos-Related lung Cancer: An underappreciated oncological issue. Lung Cancer. 2024 Aug; 194:107861.
    View in: PubMed
    Score: 0.031
  5. Thrombosis risk prediction in lymphoma patients: A multi-institutional, retrospective model development and validation study. Am J Hematol. 2024 07; 99(7):1230-1239.
    View in: PubMed
    Score: 0.031
  6. Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor versus chemotherapy. Am J Hematol. 2023 08; 98(8):1214-1222.
    View in: PubMed
    Score: 0.029
  7. Risk factors for HCC in contemporary cohorts of patients with cirrhosis. Hepatology. 2023 03 01; 77(3):997-1005.
    View in: PubMed
    Score: 0.029
  8. Influence of county-level geographic/ancestral origin on glioma incidence and outcomes in US Hispanics. Neuro Oncol. 2023 02 14; 25(2):398-406.
    View in: PubMed
    Score: 0.029
  9. Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations. Am J Hematol. 2022 08; 97(8):1044-1054.
    View in: PubMed
    Score: 0.027
  10. Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model. Cancer Res. 2021 03 15; 81(6):1607-1615.
    View in: PubMed
    Score: 0.025
  11. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nat Commun. 2020 07 03; 11(1):3353.
    View in: PubMed
    Score: 0.024
  12. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2017 Nov; 15(11):1791-1799.
    View in: PubMed
    Score: 0.019
  13. Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes. J Invest Dermatol. 2017 08; 137(8):1792-1795.
    View in: PubMed
    Score: 0.019
  14. The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium. Am J Epidemiol. 2016 Jan 15; 183(2):85-91.
    View in: PubMed
    Score: 0.017
  15. Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium. Eur J Cancer. 2013 Apr; 49(6):1335-45.
    View in: PubMed
    Score: 0.014
  16. Statistical methods for anomalous discrete time series based on minimum cell count. Biom J. 2008 Feb; 50(1):86-96.
    View in: PubMed
    Score: 0.010
  17. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol. 2006 Feb 20; 24(6):863-71.
    View in: PubMed
    Score: 0.009
  18. Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis. Cancer Res. 2005 Dec 15; 65(24):11297-303.
    View in: PubMed
    Score: 0.009
  19. Late onset and reactivation of chorioretinitis in children with congenital cytomegalovirus infection. Pediatr Infect Dis J. 1994 Dec; 13(12):1139-42.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.